|
Sickle cell disease refers to a collection of genetic blood disorders
characterized by a hemoglobin variant called HbS. Individuals who are affected
with sickle cell anemia have two copies of this beta globin variant, and the
primary hemoglobin present in their red blood cells is HbS. This disease is
particularly common among people whose ancestors come from sub-Saharan Africa,
Spanish-speaking regions (South America, Cuba, Central America), Saudi Arabia,
Oman, India, and Mediterranean countries such as Turkey, Greece, and Italy.
In an earlier study, the pro-oxidants and anti-oxidant status in patients
with sickle cell anaemia were assessed. Although available reports suggested
that sickle cell erythrocytes are susceptible to endogenous free radical
mediated oxidant damage, there remains some discrepancy in the status of
antioxidant enzymes and antioxidant vitamins in these patients. In view of this,
107 cases of sickle cell anaemia (36 ‘SS’ and 71 ‘AS’ pattern - as confirmed by
haemoglobin electrophoresis) were subjected to analysis of malondialdehyde,
ascorbic acid, superoxide dismutase and albumin. The results were compared with
54 healthy controls (age and sex matched). The results indicated a marked
increase in lipid peroxidation and superoxide dismutase levels in both ‘SS’ and
‘AS’ types of sickle cell anaemia compared to controls. Although no difference
was observed in the levels of albumin in both groups, the levels of ascorbic
acid were significantly depleted in sickle cell anaemic patients. The results
are indicative of enhanced lipid per oxidation along with imbalance in the
pro-oxidant and antioxidant status in patients with sickle cell anaemia.1
(Table 1)
*Significantly higher (p<0.001) as compare to controls, **Not
significantly different from controls, # Significantly lower (p<0.001) as
compared to controls.
In this study, the role of serum uric acid as an anti-oxidant in sickle
cell anaemia was evaluated and the results showed that enhanced oxidative stress
in sickle cell anaemia was counteracted by antioxidant uric acid leading to
lower uric acid levels.2
These facts gave an impetus to have a detailed clinical review of the
health profile in patients with sickle cell disease.
* Significantly different as compared to controls; p<0.001 # Significantly
negative correlation (r = 0.86): p<0.001
Sickle cell anemia is an inherited autosomal recessive disorder
characterized primarily by chronic anemia and periodic episodes of pain.3
Individuals who possess one copy of the normal beta globin gene (HbA) and
one copy of the sickle variant (HbS) are referred to as having the sickle cell
trait, but these individuals do not express symptoms of sickle cell disease.
Hence, sickle cell traits present with varied problems including increased
urinary tract infection in women, gross hematuria, complications of hyphema,
splenic infarction with altitude hypoxia or exercise, and life-threatening
complications of exercise, exertional heat illness (exertional rhabdomyolysis,
heat stroke, or renal failure) or idiopathic sudden death.3,4,5,6
Complications and Risks Associated with Sickle Cell Trait5,6
- Splenic infarction at high altitude, with exercise, or with hypoxemia
- Isothenuria with loss of maximal renal concentrating abilitty
- Hematuria secondary to renal papillary necrosis
- Fatal exertional heat illness with exercise
- Sudden idiopathic death with exercise
- Glaucoma or recurrent hyphema following a first episode of hyphema
- Bacteruria in women
- Bacteruria or pyelonephritis associated with pregnancy
- Renal medullary carcinoma in young people (ages 11 to 39 years)
- Early onset of end stage renal disease from autosomal dominant polycystic
kidney.
Hematological Manifestations
Pathologic processes that cause hypoxia, acidosis, dehydration,
hyperosmolality, hypothermia, or elevated erythrocyte 2, 3-DPG can transform
silent sickle cell trait into a syndrome resembling sickle cell disease with
vaso-occlusion due to rigid erythrocytes.
Compound heterozygous sickle cell disease can be mistaken as uncomplicated
sickle cell trait, particularly when an unusual globin variant is involved.
People with uncomplicated sickle cell trait have a normal blood
examination as assessed by conventional clinical methods, including normal red
cell morphology, indices, reticulocyte counts, and red blood cell survival by
chromium labeling. Conventional methods of detecting hemolysis are negative,
such as measurements of serum haptoglobin, bilirubin, and LDH. Erythrocyte
density distribution is normal, adherence to endothelium is not increased,
altered membrane lipids and proteins are not detectable, cytoplasmic inside-out
vesicles with high calcium content are absent, and permanently distorted
erythrocytes are not observed.
Life - Threatening Complications of Exercise
An important potential complication of sickle cell trait is unexpected
exercise-related death (ERD). The validity of this association aroused heated
controversy.4 The possibility that previously healthy young people
with sickle cell trait might suffer increased mortality from exercise was first
suggested by observations of enlisted recruits in US Armed Forces basic
training. A military trainee with Hb AS suffered exercise related hypernatremia
during physical training in the field. He only survived a critical illness that
included acute renal failure because of dialysis.7,8,9,10 During a
single summer, there were four exercise-related deaths among recruits at Fort
Bliss, all of whom were black and had sickle cell trait, while no recruits with
normal hemoglobin died. Only 1.5% of these recruits had sickle cell trait. The
authors suggested a significant risk association with sickle cell trait.10
The recommendations for safe exercise by individuals with sickle cell
trait are based upon the premise that the predominant cause of excess morbidity
and mortality is preventable exertional heat illness. At least half of these
cases were proven to suffer from acute exertional heat illness, with
rhabdomyolysis as the predominant component. The other half of cases died
suddenly without a clear etiology, but with evidence for increased risk of
unrecognized EHI when such evidence was sought. The controlled study supporting
this view has not undergone peer review and publication.
Splenic Infarction from sickle cell trait is more common with exercise at
high altitude but has occurred with altitude exposure at rest or with exercise
at sea level.5 The spleen is unusually susceptible to vaso-occlusion
related to hemoglobin S polymerization and red cell deformation. When persons
with hemoglobin S are exposed acutely to high altitude hypoxia, the spleen is
the organ most consistently injured by micro-vascular obstruction. Splenic
infarction usually presents as severe abdominal pain localizing within a few
hours to the left upper quadrant, accompanied by nausea and vomiting. Splinting
of the left hemithorax, left pleural effusion, and atelectasis of the left lung
often follow.
A tender enlarged spleen often becomes palpable. Fever, leukocytosis, and
an acute elevation of serum LDH (Lactate dehydrogenase) level occur during the
first 72 hours out of proportion to serum CK (creatinine kinase) levels. Splenic
infarcts are best imaged by CT scan, which usually shows a few large regions of
hemorrhage of variable size. Often small hemorrhages collect outside the splenic
capsule.9,10
Renal Complications
Examination of maximal urinary concentrating ability in people with sickle
cell trait relative to alpha globin gene number demonstrated that one or two
alpha globin gene deletions were associated with better preserved renal
function. 7
In other words, the less hemoglobin S that was present, the less renal
function that was lost. This implied a significant role of polymerized
hemoglobin S in the pathogenesis of renal isosthenuria. In some instances, the
anatomic lesions due to sickle cell trait are so distinct that a relationship to
polymerization of Hb S can be reasonably inferred. Such complications of sickle
cell trait include glaucoma or recurrence after treatment for hyphema and
splenic infarction in the absence of primary trauma, infection, inflammation or
tumor in the spleen.9,11,12
People with sickle cell trait often experience subclinical tissue
infarction from microvascular obstruction by rigid erythrocytes. Most people
with sickle cell trait develop microscopic infarction of the renal medulla
because of extreme hypoxemia, hypertonicity, acidosis, and hyperthermia of
arterial blood passing through the long vasa recta of the renal medulla promote
polymerization of deoxy-hemoglobin S.8
Flow through these vessels requires more than ten seconds, providing an
unusually long exposure time for polymerization of hemoglobin S. Cumulative
focal lesions result in loss of maximal urine concentrating ability which is
progressive with age and develops in most adults with sickle cell trait.7,8
The functional defect limits urine concentration to approximately the
osmolality of serum, causing isosthenuria rather than hyposthenuria. In people
with sickle cell trait, urine osmolality can usually reach values higher than
plasma during overnight dehydration (400 to 800 mOsmol). Although one may
speculate that this lesion might predispose to the development of mild
exertional heat illness (EHI) during exercise in hot weather, clinically
significant problems related to this deficit have not been demonstrated.
Necrosis of the renal papillae can result in hematuria, which is usually
microscopic. Gross hematuria is occasionally provoked by heavy exercise or
occurs spontaneously.5,10
Hematuria
The frequency of hematuria with sickle cell trait from renal papillary
necrosis has been accurately measured in a single large study of elderly
patients in Veterans Hospitals.9 Patients with sickle cell trait had
a 4% admission rate for hematuria, a significantly higher rate than the 2%
admission rate for patients with normal hemoglobin. The absolute rate of
substantial hematuria requiring admission was probably higher than would be the
case for a population not selected by hospitalization.
It is reasonable to conclude that sickle cell trait results in an
approximate doubling of the incidence of hematuria from an unknown absolute
incidence of 2% or less of hospitalizations. This implies that hematuria in
people with sickle cell trait is often unrelated to sickling or papillary
necrosis.8,9
Urinary Tract Infection
Studies in Jamaica, England and America established that the rates of
urinary tract infection are higher for women with sickle cell trait in
comparison to racially matched controls.3,4,6,8 This is best
established for asymptomatic bacteruria of pregnancy, in which the rate is
approximately doubled with sickle cell trait.12 Rates of
pyelonephritis may beRenal Medullary Carcinoma
Over a period of 22 years, the Genitourinary Pathology Department of the
Armed Forces Institute of Pathology collected 34 cases of a unique neoplasm,
which they named renal medullary carcinoma.14 This is a highly
aggressive carcinoma with unique radiologic signs and anatomic and microscopic
histology. Thirty-three of the thirty-four cases they described had hemoglobin S
(32 with Hb AS and one with Hb SC) and all the known victims were young people
aged 11 to 39. When race was known all were Afro-Caribbeans. Males predominated
by 3:1 to age 24, after which the case number was similar by gender.
This very rare carcinoma has unusual biologic features since it was
largely restricted to patients of African ancestry who were between 11 and 39
years of age. The relative rates of presentation with sickle cell trait versus
sickle cell disease are approximately the same as the prevalence of these two
genotypes (40 to one). In contrast to this, the prevalence of renal cell
carcinoma, a much more common tumor in this age group, is nearly 17 times higher
than predicted in people with sickle cell disease but not higher than in people
with sickle cell trait.15,16 Early diagnosis of renal medullary
carcinoma at a time which would improve survival has not yet been possible.
Other Medical Complications Associated with Sickle Cell Traits Pulmonary
In a large study of hospitalized veterans at a median age of 49 years,
Heller et al. found a statistically significant association between surrogate
markers for pulmonary embolism and sickle cell trait.11
Among patients with sickle cell trait diagnosed with pulmonary embolism
the frequency of thrombophlebitis was significantly higher but the frequency of
hemoptysis was significantly lower. This study demonstrated a two-fold increase
in essential hematuria.
A study of 355 hospitalized Afro-Caribbeans men with sickle cell trait was
conducted to examine stratification of risk by hemoglobin S fraction for
pulmonary embolism, thrombophlebitis, myocardial infarction, stroke, and
idiopathic hematuria. Hemoglobin S did not influence the frequency of these
syndromes, providing evidence that sickling is not associated with these forms
of vascular disease. However, the absence of a significant difference for
hematuria, which was influenced by hemoglobin S concentration in a larger study,
suggests that this study was not sufficiently sensitive.11,13
Complications during Surgery
Isolated case reports of unusual adverse events raise the possibility that
surgery involving hypoxia or reduced perfusion could result in vaso-occlusion
and serious complications for people with sickle cell trait. Some have
recommended exchange transfusion to reduce the fraction of cells containing
hemoglobin S prior to the tourniquet surgery or for intra-thoracic surgery,
especially open-heart surgery on cardio-pulmonary bypass.17 However,
the best published controlled study appeared to show no additional risk for
people with sickle cell trait who were not transfused, including some
intra-thoracic cases.18 A subsequent controlled study of open heart
surgery in Africa was interpreted as showing no adverse effects related to
sickling for 11 patients with sickle cell trait and two with doubly heterozygous
sickle cell disease.19 However, two patients with sickle cell trait
died from complications of surgery.
The authors attributed these deaths to unavoidable risk from severe
cardiac lesions rather than any effect from sickling.
Occular Complications
People with sickle cell trait are more susceptible to complications
following treatment of hyphema. Slow flow of relatively hypoxic fluid in the
chamber of the eye out of the filtration apparatus is a location in which both
polymerization of hemoglobin S and obstruction of flow by rigid erythrocytes is
likely.3,4,6 This can result in glaucoma and secondary hemorrhage. In
a study from Tennessee of 99 eyes from 97 children with hyphema, secondary
hemorrhage only occurred in 14 eyes of 13 children with sickle cell trait. The
frequency with sickle cell trait was 64%, significantly higher than among 57
eyes without sickle cell trait (0%).
Complications attributed by some to sickle cell trait include
proliferative retinopathy, worsening of diabetic retinopathy, stroke, myocardial
infarction, leg ulcers, avascular necrosis and arthritis of joints, and
increased frequency of the bends from diving. There is no convincing evidence
that sickle cell trait increases the incidence of these problems.
Some case reports may represent situations in which other variants of beta
or alpha globin produced undiagnosed sickle cell disease.4,6,20,21
Others may be the consequence of phenotypes with increased 2,3-DPG or with
arterial desaturation which has increased the rate of polymerization of
hemoglobin S sufficiently to convert a patient with sickle cell trait into
phenotypic sickle cell disease.6,18,22
Only analysis at the level of a research laboratory can detect the second
abnormality in the hemoglobin molecule. The mutant hemoglobin was named
hemoglobin S Antilles, since the patient came to Paris from the French Antilles.
Hemoglobin S Antilles is much less soluble than hemoglobin S. The consequence is
that people heterozygous for hemoglobin A and hemoglobin S Antilles have
symptoms and complications similar to those of patients with homozygous sickle
cell disease.24,25
Conclusion
People with sickle cell disease can live full lives and enjoy most of the
activities that other people do. There are things that people with sickle cell
disease can do to stay as healthy as possible.25,26,27 Below are a
few examples:
- Get regular checkups. Regular health checkups with a primary care doctor
can help prevent some serious problems.
- Prevent infections. Common illnesses, like the flu, can quickly become
dangerous for a child with sickle cell disease. The best defense is to take
simple steps to help prevent infections.
- Learn healthy habits. People with sickle cell disease should drink 8 to 10
glasses of water every day and eat healthy food. They also should try not to get
too hot, too cold, or too tired.
- Look for clinical studies. New clinical research studies are happening all
the time to find better treatments and, hopefully, a cure for sickle cell
disease. People who participate in these studies might have access to new
medicines and treatment options.
- Get support. Find a patient support group or community-based organization
in your area that can provide information, assistance, and support.
Although there has been extensive clinical and basic science research in
SCD, many public health issues, such as blood safety surveillance, compliance
with immunizations, follow-up of newborns with positive screening tests, stroke
prevention, pregnancy complications, pain prevention, quality of life, and
thrombosis, in people with SCT remain unaddressed. Currently, efforts are under
way to strengthen SCD-related activities within the Center for Disease Control
and Prevention (CDC).27 In the US, all states and the District of
Columbia have universal newborn screening (NBS) programs for sickle cell disease
(SCD), which also identify sickle cell trait.
Local screening activities may have had an impact on participation in
specialized SCD care and the disease-associated mortality rate. The incidence of
Hb SS has remained unchanged over 27 years, and that of Hb S trait and the S
allele has been unaffected in the last 18 years. Trait notification goals and
approaches should be reevaluated. There is significant misinformation about what
it means to be a carrier and its health and reproductive implications. Formal
professional counseling is rare, especially for those families without an
affected proband. Strategies to increase the utilization of counseling and
improve genetic literacy are necessary.26,28,29
ACKNOWLEDGEMENTS
The author reported no conflict of interest and no funding has been
received on this work.
REFERENCES |
|
|
- Jyoti T, Suresh C, Madhur G, Nitin PJ. Pro-Oxidant and Anti-oxidant status
in patients of sickle cell anaemia. Indian J Clin Biochem 2004; 19(2):168-172.
- Jyoti T, Madhur G, Nitin PJ, SN Chari. Role of serum uric acid as an
antioxidant in sickle cell anaemia. Ind Med Gaz 2005; 3:97-99.
- Sears DA. The morbidity of sickle cell trait: a review of the literature.
Am J Med 1978 Jun; 64(6):1021-1036.
- Serjeant GR. The sickle cell trait. In: Serjeant GR, ed., Sickle cell
disease. New York City, Oxford University Press, 1992: 415-425.
- Kark JA, Ward FT. Exercise and hemoglobin S. Semin Hematol 1994 Jul;
31(3):181-225.
- Eichner ER. Sickle Cell Trait. J Sport Rehabil 2007 Aug; 16(3):197-203.
- Gupta AK, Kirchner KA, Nicholson R, Adams III JG, Schechter AN, Noguchi
CT, Steinberg MH. Effects of a-thalassemia and sickle polymerization tendency on
the urine-concentrating defect of individuals with sickle cell trait. J Clin
Invest 1991 Dec; 88:1963-1968.
- Statius Van Eps LW, De Jong PE. Sickle Cell Disease., In: Schrier RW,
Gottschalk, CW, eds. Disease of the Kidney, 1997; p. 2201-2219.
- López de Guimaraes D, Menacho López J, Villanueva Palacios J, Mosquera
Vásquez V. Splenic infarct at high altitude, Huaraj (3100 masl). Rev
Gastroenterol Peru. 2009 Jun; 29(2):179-184.
- Jones SR, Binder RA, Donowho EM Jr: Sudden death in sickle cell trait. N
Engl J Med 1970; 282:323-325.
- Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle
cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized
black male patients. N Engl J Med 1979; 300:1001-1005.
- Bencaiova G, Krafft A, Breymann CH. Sickle cell trait and urinary tract
infection in pregnanacy. Int J Gynaecol Obstet 2006 Feb; 92(2):128-129.
- Yium J, Gabow P, Johnson A, Kimberling W, Martinez-Maldonado M. Autosomal
dominant polycystic kidney disease in blacks: clinical course and effects of
sickle cell hemoglobin. J Am Soc Nephrol 1994; 92:119-122.
- Srigley JR, Delahunt B. Uncomman and recent described renal carcinomas.
Mod Pathol 2009 June; 2(2):2-23.
- Avery RA, Harris JE, Davis CJ Jr, Borgaonkar DS, Byrd JC, Weiss RB. Renal
medullary carcinoma: clinical and therapeutic aspects of a newly described
tumor. Cancer 1996; 78:128-132.
- Leitão VA, da Silva W Jr, Ferreira U, Denardi F, Billis A, Rodrigues Netto
N Jr. Renal Medullary Carcinoma. Case report and review of literature. Urol Int
2006 Aug; 77(2):184-186.
- Scott-Connor CEH, Brunson CD. Surgery and anesthesia. In: Embury SH,
Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles
and clinical practice. New York, Raven Press, 1994: 809-27.
- Atlas SA. The sickle cell trait and surgical complications. A matched pair
patient analysis. JAMA 1974; 229:1078-1080.
- Metras D, Ouezzin Colibaly A, Ouattara K, Longechaud A, Millet P, Chauvet
J. Open-heart surgery in sickle cell haemoglobinopathies: report of 15 cases.
Thorax 1982 Jul; 37(7): 486-491.
- Castro O, Rana S. Approach to patients with special red blood cell
disorders: sickle hemoglobinopathies, polycythemia, and autoimmune hemolytic
anemias. In: Spiess, B, ed. Perioperative Transfusion Medicine. Baltimore,
Williams & Wilkins, 1998: 231-232.
- Acharya K, Lang CW, Ross LF. A Pilot study to explore knowledge,
attitudes, and beliefs about sickle cell trait and disease. J Natl Med Assoc
2009 Nov; 101(11):1163-1172.
- Cohen-Solal M, Prehu C, Wajcman H, Poyart C, Bardakdjian-Michau J, Kister
J, et al. A new sickle cell disease phenotype associating Hb S trait, severe
pyruvate kinase deficiency (PK Conakry), and an aplha2 globin gene variant (Hb
Conakry). Br J Haemotol 1998 Dec; 103(4): 950-956.
- Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complication
associated with sickle cell trait: a brief narrative view. Am J Med 2009 Jun;
122 (6):507-512.
- Monplaisir N, Merault G, Poyart C, Rhoda MD, Craescu C, Vidaud M, et al. A
variant with lower solubility than hemoglobin S and producing sickle cell
disease in heterozygotes. Proc Natl Acad Sci USA 1986; 83:9363-9367
- Creary M, Williamson D, Kulkarni R. J. Sickle cell disease: current
activities, public health implications and future directions. Womens Health
(Larchmt) 2007 Jun; 16(5):575-582. Review.
- Treadwell MJ, McClough L, Vichinsky E. Using qualitative and quantitative
strategies to evaluate knowledge and perceptions about sickle cell disease and
sickle cell trait. Natl Med Assoc 2006 May; 98(5):704-710.
- Pack-Mabien A, Haynes J Jr. A primary care provider’s guide to preventive
and acute care management of adults and children with sickle cell disease. J Am
Acad Nurse Pract 2009 May; 21(5):250-257. Review.
- Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H. Communication of
positive newborn screening results for sickle cell disease and sickle celltrait:
variation across the state.Am J Med Genet C Semin Med Genet 2008 Feb;
15(1):15-22.
- Lerner NB, Platania BL, LaBella S. Newborn sicke cell screening in a
region of Western New York state. J Pediatr 2009 Jan; 154(1):121-125.
|